Parmax Pharma Board Meeting for Q2 FY2027 Results

Key Details

Board Meeting Agenda

The Board of Directors meeting is scheduled for Friday, November 13, 2026. The agenda includes two items:

1. To consider and approve the unaudited financial results for the quarter and half year ended on September 30, 2026.

2. To discuss the shifting of the Registered Office of the Company.

Trading Window Closure

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal code, the trading window for dealing in the company's securities is closed. The closure is in effect until forty-eight hours after the announcement of the aforementioned financial results.